Showing results (251-260 of 16,630) with videos related to
Sort By:
Pageof 1,663
Cancer Letters|July 23, 2022
CD155 in tumor progression and targeted therapyMeixiao Zhan, Zhiren Zhang, Xiaoguang Zhao, et al.Cancer Letters|July 25, 2022
PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivoYonggang Sha, Jian Wu, Barry Paul, et al.Cancer Letters|July 14, 2022
Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapyQiushi Tang, Shuo Yang, Guangpeng He, et al.Cancer Letters|June 22, 2018
Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancerKei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.Cancer Letters|September 15, 2018
Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathwayPing Yang, Chunxiao Su, Xuan Luo, et al.Cancer Letters|September 15, 2018
Pre-malignant transformation by senescence evasion is prevented by the PERK and ATF6alpha branches of the Unfolded Protein ResponseClaire Drullion, Guillemette Marot, Nathalie Martin, et al.Cancer Letters|September 12, 2018
Targeting SLC25A10 alleviates improved antioxidant capacity and associated radioresistance of cancer cells induced by chronic-cycling hypoxiaJulian Hlouschek, Violetta Ritter, Florian Wirsdörfer, et al.Cancer Letters|September 12, 2018
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP releaseAloran Mazumder, Jin-Young Lee, Oualid Talhi, et al.Cancer Letters|July 1, 1986
Inhibition of mitochondrial protein synthesis leads to proliferation arrest in the G1-phase of the cell cycleC van den Bogert, G van Kernebeek, L de Leij, et al.Cancer Letters|September 4, 2018
Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblastsInes Barone, Valentina Vircillo, Cinzia Giordano, et al.Pageof 1,663